Pacira BioSciences, Inc.

PCRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001396814

SEC filings (opens in a new tab)

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding Pacira BioSciences, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025 All holders in Q4 2024

13F holders of PCRX: Q4 2024 compared with Q1 2025
Measure	Q4 2024	Of which not filed for Q1 2025	Q1 2025	Change
Holders	233	2	235	+4
Shares	49.9M	626.3K	50.6M	+1.31M (+2.7%)
Value	$940.6M	$11.8M	$1.26B	+$328.7M (+35.4%)

2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Pacira BioSciences, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to PCRX in Q1 2025
Institution	Shares	Value	% of portfolio
Alyeska Investment Group, L.P.	1,308,086	$32.5M	0.13%
Nuveen, LLC	518,482	$12.9M	0.00%
Phocas Financial Corp.	142,443	$3.54M	0.54%
Danske Bank A/S	61,327	$1.52M	0.00%
Caxton Associates LLP	51,764	$1.29M	0.04%
First Trust Advisors LP	49,192	$1.22M	0.00%
Man Group plc	48,635	$1.21M	0.00%
Diadema Partners LP	38,926	$967.3K	0.77%
Martingale Asset Management L P	32,484	$807.2K	0.02%
Virginia Retirement Systems Et Al	29,200	$725.6K	0.01%
Franklin Resources Inc	28,111	$698.6K	0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH	15,786	$392.3K	0.00%
Natixis Advisors, L.P.	13,139	$327.0K	0.00%
Wolverine Asset Management LLC	11,628	$289.0K	0.01%
Allspring Global Investments Holdings, LLC	11,488	$276.5K	0.00%
Commonwealth of Pennsylvania Public School Empls Retrmt Sys	11,050	$274.6K	0.00%
Gsa Capital Partners LLP	10,973	$273.0K	0.02%
CIBC World Markets Corp	10,169	$252.7K	0.00%
Rafferty Asset Management, LLC	10,092	$250.8K	0.00%
FORA Capital, LLC	9,457	$235.0K	0.02%
Persistent Asset Partners Ltd	8,963	$222.7K	0.20%
Massar Capital Management, LP	8,500	$211.2K	0.25%
Virtus ETF Advisers LLC	6,765	$168.1K	0.11%
Caitong International Asset Management Co., Ltd	2,044	$50.8K	0.04%
Coldstream Capital Management Inc	1,585	$39.4K	0.00%
Farther Finance Advisors, LLC	509	$12.3K	0.00%
Macquarie Group Ltd	469	$11.7K	0.00%
Hollencrest Capital Management	428	$10.6K	0.00%
Federation des caisses Desjardins du Quebec	190	$4.72K	0.00%
1 North Wealth Services LLC	165	$4.10K	0.00%
Vision Financial Markets LLC	100	$2.48K	0.00%
CIBC Private Wealth Group, LLC	83	$2.18K	0.00%
Aspect Partners, LLC	48	$1.19K	0.00%
Hantz Financial Services, Inc.	58	$1.00K	0.00%
Binnacle Investments Inc	8	$199	0.00%

Sold out (31)

Institutions that held Pacira BioSciences, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of PCRX in Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Point72 Asset Management, L.P.	1,075,673	$20.3M
Schonfeld Strategic Advisors LLC	271,654	$5.12M
Trexquant Investment LP	198,090	$3.73M
Cubist Systematic Strategies, LLC	186,952	$3.52M
Capital Fund Management S.A.	175,225	$3.30M
Norges Bank	127,655	$2.41M
Qube Research & Technologies Ltd	84,039	$1.58M
Squarepoint Ops LLC	60,836	$1.15M
Caption Management, LLC	53,844	$1.01M
Marshall Wace, LLP	42,613	$802.8K
Janney Montgomery Scott LLC	29,395	$554.0K
Algert Global LLC	26,625	$501.6K
EntryPoint Capital, LLC	23,021	$433.7K
Jain Global LLC	17,906	$337.3K
Outfitter Financial LLC	13,065	$246.1K
Dark Forest Capital Management LP	11,658	$219.6K
State of Wyoming	6,566	$123.7K
Virtus Investment Advisers, Inc.	6,500	$122.5K
Point72 (DIFC) Ltd	6,370	$120.0K
Point72 Asia (Singapore) Pte. Ltd.	5,450	$102.7K
Parallax Volatility Advisers, L.P.	5,357	$100.9K
Headlands Technologies LLC	5,082	$95.7K
Vestcor Inc	3,459	$65.0K
Caitlin John, LLC	1,872	$35.3K
Raleigh Capital Management Inc.	537	$10.1K
Point72 Hong Kong Ltd	200	$3.77K
Van Hulzen Asset Management, LLC	150	$2.83K
Barrow Hanley Mewhinney & Strauss LLC	60	$1.13K
Continuum Advisory, LLC	27	$509
Mattson Financial Services, LLC	15	$226
Elequin Capital LP	4	$75

Not filed for Q1 2025 yet (2)

Institutions that held Pacira BioSciences, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCRX in Q4 2024 that haven't filed for Q1 2025
Institution	Shares, Q4 2024	Value, Q4 2024
Nuveen Asset Management, LLC	625,917	$11.8M
Global Retirement Partners, LLC	350	$6.59K